ASX:MVP Medical Developments International (MVP) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Medical Developments International Stock (ASX:MVP) 30 days 90 days 365 days Advanced Chart Remove Ads Get MVP alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume169,499 shsAverage VolumeN/AMarket Capitalization$98.01 millionP/E RatioN/ADividend Yield0.77%Price TargetN/AConsensus RatingN/A Company OverviewMedical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.Read More… Remove Ads Receive MVP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medical Developments International and its competitors with MarketBeat's FREE daily newsletter. Email Address MVP Stock News HeadlinesMedical Developments International Appoints New DirectorMarch 31 at 8:23 PM | tipranks.comMedical Developments International Limited (ASX:MVP) Shares Could Be 38% Below Their Intrinsic Value EstimateMarch 25, 2025 | finance.yahoo.comTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. April 2, 2025 | Paradigm Press (Ad)Medical Developments International Limited (MVP) was downgraded to a Hold Rating at Bell PotterMarch 25, 2025 | markets.businessinsider.comMedical Developments International Limited (MVP.AX)February 1, 2025 | ca.finance.yahoo.comMedical Developments International Shares Business OutlookNovember 21, 2024 | markets.businessinsider.comMedical Developments International Insiders Placed Bullish Bets Worth AU$3.36mNovember 21, 2024 | finance.yahoo.comDown goes the MVP: Ohtani wouldn’t be first to suffer October injury; Judge has unreal O-ferOctober 27, 2024 | nytimes.comSee More Headlines MVP Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Medical Developments International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medical Developments International investors own include Core Lithium (CXO), Bubs Australia (BUB), Talon Energy (TPD), Qantas Airways (QAN), Mesoblast (MESO), LINE (LN) and Harvey Norman (HVN). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:MVP CIKN/A Webwww.medicaldev.com Phone61 3 9547 1888FaxN/AEmployees68Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-40,990,000.00 Net Margins-123.66% Pretax MarginN/A Return on Equity-67.52% Return on Assets-11.21% Debt Debt-to-Equity Ratio5.00 Current Ratio2.74 Quick Ratio2.54 Sales & Book Value Annual Sales$33.15 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow21.37 Book ValueA$0.52 per share Price / BookN/AMiscellaneous Outstanding Shares112,660,000Free FloatN/AMarket Cap$98.01 million OptionableNot Optionable Beta1.63 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (ASX:MVP) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medical Developments International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Medical Developments International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.